In accordance with the present invention, there are provided methods fortreating hyperplasia in a subject in need thereof. In another aspect of theinvention, there are provided methods for reducing neointimal hyperplasiaassociated with vascular interventional procedures. Formulations contemplatedfor use herein comprises proteins and at least one pharmaceutically activeagent.
